CRYO Stock UPDATES Cryo-Save Group N.V. (CRYO) 0.3600 08/28/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cryo-Save Group N.V. (CRYO) 0.3600 $CRYO

American CryoStem Enters Into Definitive Term Sheet With Health Innovative Technology Corporation Limited
GlobeNewswire - Wed Jul 02, 8:57AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that it has made a major step in establishing a global footprint for its cellular technology and laboratory processing platform by entering into an agreement to license its ATGRAFT(TM) adipose tissue (fat) processing and storage technologies with Health Innovative Technology Corporation Limited (HIT), a Hong Kong corporation. HIT currently operates a cellular processing and banking platform and a chain of medical centers, offering comprehensive healthcare solutions to clients in Hong Kong.

American CryoStem Announces Agreement With the nanoRANCH Division of UHV Technologies for Cancer Research Utilizing ATCELL(TM)
GlobeNewswire - Wed Jun 18, 9:17AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that the Company has entered into initial agreements with the nanoRANCH Division of UHV Technologies, Inc. ("nanoRANCH" for the development of methods for the delivery of therapeutics and drugs focused upon cancer treatments utilizing adipose derived adult stem cells. The Company will be working with Dan Dimitrijevich, PhD to create new treatment delivery methods utilizing a combination of nanoRANCH unique technology and CRYO's clinically processed ATCELLs(TM).

Rent-A-Center, Inc. Announces Fourth Quarter and Year End 2013 Earnings Call and Webcast
GlobeNewswire - Wed Jan 15, 11:16AM CST
Rent-A-Center, Inc. (Nasdaq:RCII) today announced it will host a conference call on Tuesday, January 28, at 10:45 a.m. ET to discuss fourth-quarter results slated for release following the market's close on January 27. Live audio of the conference call will be available on the company's investor relations website at http://investor.rentacenter.com. A replay will be available beginning January 28 at 1:45 p.m. ET.

American CryoStem Posts Letter to Shareholders
GlobeNewswire - Mon Jan 06, 12:45PM CST
John Arnone, Chairman and CEO of American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today issued a formal update in the form of a Letter to Shareholders posted to the Company's web site at www.americancryosystem.com.

Best's Rating Notification - Cincinnati Life Insurance Company
Rating Division - AMBest - Thu Dec 19, 1:14PM CST
A.M. Best Company has made the following rating update:

American Cryostem Granted Interlinked an Exclusive Interview During Recent FSXinterlinked Investment Conference
PRWeb - Tue Aug 27, 3:38AM CDT
At the recent FSXinterlinked Investment Conference, held at the Ritz Carloton in Fort Lauderdale, Florida, American Cryostem's Chairman and CEO, John Arnone, granted an exclusive interview for the FSXinterlinked channel on InterlinkedTV.

American CryoStem Granted IRB Approval for Adipose Derived Stem Cell Processing Protocols
GlobeNewswire - Wed Jul 10, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that its protocols for the processing of Stromal Vascular Fraction (SVF) and culturing of mesenchymal stem cells from autologous adipose tissue have been approved by the Institutional Review Board (IRB) of the International Cell Surgical Society (ICSS).

American CryoStem to Present at OneMedForumNY 2013
GlobeNewswire - Wed Jun 26, 8:35AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that the Company has been invited to present at OneMedForumNY 2013 to be held at the Metropolitan Club in New York City, June 26-27, 2013.

Under-valued Stem Cell Innovator Targets Growing Markets
ACCESSWIRE - Wed Jun 26, 8:00AM CDT
American CryoStem (CRYO) Targets Growing End Markets

American CryoStem Welcomes Noted Cryopreservation Expert, Dr. Dayong Gao, to Medical & Scientific Advisory Board
GlobeNewswire - Mon Jun 24, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that Dayong Gao, Ph.D. has been appointed to the Company's Medical and Scientific Advisory Board.

Fat Cells Lending to New Treatments in Brain Cancer
ACCESSWIRE - Thu Jun 13, 12:30PM CDT
Regenerative medicines hold incredible potential for new, more potent therapeutics to arrive in the future for a broad spectrum of diseases and conditions. As the industry in general is growing, more possibilities are emerging seemingly on a daily basis as research uncovers new ways to use stem cells to potentially combat deadly diseases like cancer where many patients have little to no hope with today's standards of care.

American CryoStem to Present at National Investment Banking Association's 126th Investment Conference
GlobeNewswire - Tue Jun 04, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that the Company has been invited to present at the National Investment Banking Association's (NIBA) 126 Investment Conference to be held in New York City, June 17-19, 2013.

Investment Ideas in the Expanding Wound Care Market
ACCESSWIRE-TNW - Fri May 17, 10:55AM CDT
Investing in Wound Care's Real Growth Drivers

American CryoStem Partners with Rutgers for Novel Wound Care Product
ACCESSWIRE-TNW - Tue May 14, 11:01AM CDT
Regenerative medicine is constantly discovering new inroads to potential therapies utilizing adult stem cells for a variety of life threatening or debilitating conditions and diseases. Progress has accelerated in the past few years, fueled in part by President Obama's 2009 Executive Order 13505 that "removed barriers" in responsible research which has opened doors to examination of new ways of thinking. It has also aided in the emergence of research in the area of adipose (fat)-based stem cell therapy, which could prove to be a major breakthrough in regenerative medicine. Not only has early research at Johns Hopkins suggested the possibility of superior efficacy with Adipose-Derived Stem Cells, or ADSCs, in the treatment of glioblastoma (a severe form of brain cancer), but ADSCs are easily harvested, meaning that they could become a standard as the most reliable and abundant source of stem cells for research, cultures and therapeutic processes.

American CryoStem to Collaborate With Rutgers University on Adipose-Derived Stem Cell Research
GlobeNewswire - Tue May 14, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based and cellular technologies for the Regenerative and Personalized Medicine industries, today announced that it has entered into Material Transfer Agreements with three leading research scientists at Rutgers, The State University of New Jersey, distinguished as one of the world's premier universities for stem cell research and training.

The Beauty of American CryoStem Now and in the Future
ACCESSWIRE-TNW - Thu May 09, 1:12PM CDT
"What can I do with my unwanted body fat?" That is a question that is posed by American CryoStem (OTCQB: CRYO) on the home page of its website. There are plenty of finite resources in the world, but let's face it, body fat certainly isn't one of them. A little due diligence reveals the company's answer to that question, but a more discerning examination uncovers the true growth potential of American CryoStem from an immediate, mid-term and long-term perspective.

Use Your Own Stem Cells to Combat Aging Skin
ACCESSWIRE-TNW - Tue Apr 30, 5:12PM CDT
American Cryostem (OTCQB: CRYO) is a pioneer in the fields of regenerative and personalized medicine. Their multi-faceted business model involves the patented collection and storage of adipose-derived regenerative cells (ADRC's). The fat that is collected from the patient's own body can be used in cosmetic procedures like breast and buttock enhancements, which alone is a large market opportunity. However, a more intriguing proposition lies in the world of autologous, stem-cell based cosmetics treatments designed to combat the effects of aging on skin.

American CryoStem Marks Major Global Expansion Milestone: Receives First International Shipment of Adipose Tissue for Processing and Cryo-Storage From Hong Kong
GlobeNewswire - Tue Apr 23, 9:45AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced receipt of its first commercial international shipment of adipose tissue for processing and long term cryo-storage.

Adipose Derived Stem Cells Providing a Bridge to the Future of Regenerative Medicine
ACCESSWIRE-TNW - Thu Apr 18, 8:54AM CDT
Regenerative medicines are finally coming into their own as validated therapies for treatment of a wide spectrum of conditions and diseases. Years of research are now behind the industry and naysayers have been silenced with compilations of data demonstrating the use of stem cells to help the body heal itself. Of course, regenerative medicine is still relatively young and a moving target with new discoveries popping up and then being reinforced. A case in point is the recent work of Johns Hopkins University School of Medicine showing that mesenchymal stem cells derived from adipose (fat) tissue might be far more efficient in the treatment of glioblastoma, the most common form of brain cancer, than those derived from bone marrow, as scientists first thought. Cells derived from fat tissue can obviously be gathered in a far less invasive - and less expensive - manner.

American CryoStem to Exhibit at The Aesthetic Meeting
GlobeNewswire - Thu Apr 11, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading biotech company in the field of Regenerative Medicine, today announced that the Company is scheduled to exhibit at The Aesthetic Meeting 2013, held this week, April 11-16 in New York City, at the Jacob Javits Convention Center. The Company will be showcasing its latest adipose tissue (fat) collection, processing and storage service, ATGRAFT(TM) and complimentary personalized skin care products. With one liposuction, ATGRAFT(TM) is a complete fat tissue storage solution for physicians to perform layered fat transfers and provides patients additional opportunities to use their stored fat tissue to create personalized skin care products or clinically processed stem cells for use in Regenerative Medicine treatments.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 70

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 548

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 53

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 306

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 52

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 160

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 458

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 117

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 124

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading

Top 5 Most Recently Viewed Articles

WIC Forum Set to Transform Cultural Heritage through Digitalization

Updated Category News Views 194

WIC Forum Set to Transform Cultural Heritage through Digitalization The World Internet Conference (WIC) recently held a significant press conference to announce the upcoming Cultural Heritage Digitalization Forum. This important event aims to explore the relationship between technology and cultural heritage preservation. Event Overview The WIC's briefing included key...

Continue Reading
Nordea Bank Rectifies Errors in Exchange Traded Products

Updated Category News Views 194

Correction of Errors in Exchange Traded Products Nordea Bank Abp, acting as the issuer, has identified and decided to amend certain final terms related to instruments listed in their documentation. This corrective action is taken based on identified manifest errors that needed rectification. The bank is entitled to make such modifications under subsection (i) of Condition...

Continue Reading
NEXE Innovations 2024 Review: A New Era of Sustainability Ahead

Updated Category News Views 324

Strategic Developments at NEXE Innovations NEXE Innovations Inc. (TSXV: NEXE) is making headlines with its impressive strides toward sustainable growth. This innovative company is dedicated to developing compostable materials to meet the rising demand for eco-friendly solutions. Their focus is on high-performance products that serve various markets, creating robust...

Continue Reading
Analyzing Affiliated Managers Group's Price-to-Earnings Ratio

Updated Category News Views 144

Understanding Affiliated Managers Group's Stock Performance In today's market, Affiliated Managers Group Inc. (NYSE: AMG) is trading at $281.79, reflecting a slight increase of 0.97%. Over the last month, the stock has appreciated by 5.89%, showcasing an impressive 50.30% rise over the past year. Such robust performance invites optimism among long-term investors, although...

Continue Reading
Revolutionizing Medical Device Development Through Live Prototyping

Updated Category News Views 182

Accelerating Medical Device Innovation In the fast-evolving world of healthcare technology, the demand for speed and efficiency has never been more critical. Elevaris Medical Devices, a prominent Contract Development and Manufacturing Organization (CDMO), is at the forefront of this transformation. They specialize in working with multi-national healthcare firms, global...

Continue Reading